Skip to main content
Log in

Noninvasive assessment of the inodilator action of amrinone in healthy man

  • Originals
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

Summary

The effects of a single dose of 2 mg/kg amrinone (60 min constant rate IV infusion) have been assessed in a double-blind, placebo-controlled, within-subject cross-over study in six healthy volunteers. Combined impedance cardiography, phonocardiography and electrocardiography revealed a protracted drop in mean ventricular ejection time and electromechanical systole together, with a protracted rise in the “contractility” indices dZ/dtmax and the Heather index HI. The profile is compatible with combined venous vasodilation and positive inotropic action. In spite of the methodological constraints, endpoints were reached that were both detectable and relevant. The profiling permitted a better distinction to be made between the possible levels of action than systolic time intervals alone could have done. Therefore, these methods may be of value in the early development of “inodilator” drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Marcus FI, Opie LH, Sonnenblick EH (1987) Digitalis and inotropic-dilators. In Drugs for the heart Opie LH (ed) Grune and Stratton, p 101

  2. de Mey C, Enterling D (1986) Assessment of the hemodynamic response to passive head up tilt by non-invasive methods in normal subjects. Meth Find Exptl Clin Pharmacol 8: 449–457

    Google Scholar 

  3. de Mey C, Enterling D (1987) Non-invasive estimates of cardiac performance during and immediately after single and repeated passive upright tilt in normal man: volume dependency of systolic time intervals and maximum velocity of transthoracic impedance changes. Am J Noninvasive Cardiol 1: 188–196

    Google Scholar 

  4. de Mey C, Enterling D, Wesche H, Brendel E (1988) Pharmacokinetic and pharmacodynamic effects of single oral doses of ibopamine, quinidine and their combination in normal man. Eur J Clin Pharmacol 34: 415–418

    Google Scholar 

  5. de Mey C, Hansen-Schmidt S, Enterling D, Meineke I (1989) Time course and nature of postprandial hemodynamic changes in normal man. Clin Physiol 9: 77–87

    Google Scholar 

  6. de Mey C, Enterling D, Meineke I (1989) Pharmacokinetic and pharmacodynamic interactions between single oral doses of ibopamine and food in normal man. Drug Res 39: 1138–1143

    Google Scholar 

  7. Ebert TJ, Smith JJ, Barney JA, Merrill DC, Smith GK (1986) The use of thoracic impedance for determining thoracic blood volume changes in man. Aviat Space Environ Med 57: 49–53

    Google Scholar 

  8. Lababidi Z, Ehmke DA, Durnin RE, Leaverton PE, Lauer RM (1970) The first derivative thoracic impedance cardiogram. Circulation 41: 651–658

    Google Scholar 

  9. Welham KC, Mohapatra SN, Hill DW, Stevenson L (1978) The first derivative of the transthoracic electrical impedance as an index of changes in myocardial contractility in the intact anaesthetised dog. Intens Care Med 4: 43–50

    Google Scholar 

  10. Weissler AM, Harris WS, Schoenfeld CD (1968) Systolic Time Intervals in heart failure in man. Circulation 37: 149–159

    Google Scholar 

  11. Kubicek WG, Karnegis JN, Patterson RP, Witsoe DA, Mattson RH (1966) Development and evaluation of an impedance cardiac output system. Aerosp Med 37: 1208–1212

    Google Scholar 

  12. Geddes LA and Sadler C (1973) The specific resistance of blood at body temperature. Med Biol Eng 5: 336–339

    Google Scholar 

  13. Siegel JH, Fabian M, Lankau C, Levine M, Cole A, Nahmad M (1970) Clinical and experimental use of thoracic impedance plethysmography in quantifying myocardial contractility. Surgery 57: 907–917

    Google Scholar 

  14. Hill DW, Merrifield AJ (1976) Left ventricular ejection and the Heather Index measured by non-invasive methods during postural change in man. Acta Anaesth Scand 20: 313–320

    Google Scholar 

  15. Opie LH (1986) Inodilators. Lancet I: 1336

    Google Scholar 

  16. Tan LB, Murray RG, Littler WA (1987) An analytical method to separate inotropic and vasodilatory drug effects in patients with heart failure. Cardiovasc Res 21: 625–630

    Google Scholar 

  17. Stern HC, Wolf GK, Belz GG (1985) Comparative measurements of left ventricular ejection time by mechano-, echo- and electrical impedance cardiography. Drug Res 35: 1582–1586

    Google Scholar 

  18. de Mey C, Belz GG (1989) Pitfalls and limitations in the usage of impedance cardiography. Br Heart J 61: 128–129

    Google Scholar 

  19. Stern H, Matthews J, Belz G (1984) Influence of dihydralazine induced afterload reduction on systolic time intervals and echocardiography in healthy subjects. Br Heart J 52: 435–439

    Google Scholar 

  20. Nakamura Y, Wiegner AW, Gaasch WH, Bing OHL (1983) Systolic time intervals: assessment by isolated cardiac muscle studies. JACC 2: 973–978

    Google Scholar 

  21. Buch J, Egeblad H, Hansen PB, Kjaergard H, Waldoff S, Steiness E (1980) Correlation between changes in systolic time intervals and left ventricular end-diastolic diameter after preload reduction. Br Heart J 44: 668–671

    Google Scholar 

  22. Cardenas LM, Vidaurri DA (1979) Estudio de los efectos hemodynamicos de differentes dosis de un nuevo inotropico: la amrinona. Arch Inst Cardiol Mex 49: 961–968

    Google Scholar 

  23. Hermiller JB, Leithe ME, Magorien RD, Unverferth DV, Leier CV (1984) Amrinone in severe congestive heart failure: another look at an intriguing new cardioactive drug. J Pharmacol Exp Ther 228: 319–326

    Google Scholar 

  24. Wilmshurst PT, Thompson DS, Jenkins BS, Coltart DJ, Webb-Pepole MM (1983) Hemodynamic effects of intravenous amrinone in patients with impaired left ventricular function. Br Heart J 49: 77–82

    Google Scholar 

  25. Wilmshurst PT, Thompson DS, Jull SM, Jenkins BS, Coltart DJ, Webb-Peploe MM (1984) Comparison of the effect of amrinone and sodium nitroprusside on hemodynamics, contractility and myocardial metabolism in patients with cardiac failure due to coronary artery disease and dilated cardiomyopathy. Br Heart J 52: 38–48

    Google Scholar 

  26. Benotti JR, Grossman, Braunwald E, Davolos DD, Alousi AA (1978) Hemodynamic assessment of amrinone. N Engl J Med 299: 1373–1377

    Google Scholar 

  27. Firth BG, Rather AV, Grassman ED, Winnford MD, Nicod P, Hillis LD (1984) Assessment of the inotropic and vasodilator effects of amrinone versus isoproterenol. Am J Cardiol 54: 1331–1336

    Google Scholar 

  28. Thormann J, Kramer W, Kindler M, Kremer P and Schlepper M (1987) Bestimmung der Wirkkomponenten von Amrinon durch kontinuierliche Analyse der Druck-Volumen-Beziehungen; Anwendung der Conductance-(Volumen-)Kathetertechnik und der schnellen Laständerung durch Ballonokklusion der Vena Cava inferior. Z Kardiol 76: 530–540

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

de Mey, C., Enterling, D. & Hanft, G. Noninvasive assessment of the inodilator action of amrinone in healthy man. Eur J Clin Pharmacol 40, 373–378 (1991). https://doi.org/10.1007/BF00265846

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00265846

Key words

Navigation